Literature DB >> 17197010

N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport.

Bobbie R Erickson1, Varough Deyde, Angela J Sanchez, Martin J Vincent, Stuart T Nichol.   

Abstract

The mature Gn glycoprotein of Crimean Congo hemorrhagic fever (CCHF) virus contains two predicted glycosylation sites (557N and 755N). Of these, N-glycans are added only at 557N, as evidenced by abrogation of Gn-glycosylation by mutation of 557N but not 755N site. Mutational block of Gn-glycosylation at 557N did not significantly affect Gn proteolytic processing but did result in mislocalization and retention of Gn and other proteins synthesized from the virus M segment ORF (GP160, GP85, GP38 and Gc) in the endoplasmic reticulum. In contrast to Gn, similar mutational analysis demonstrated that, while N-glycosylation occurs at the two predicted sites in Gc, abrogation of their glycosylation did not alter localization of any of the CCHF virus glycoproteins. Studies of Gn expressed in the absence of Gc demonstrate that, while Gn processing and localization are independent of Gc, all the CCHF virus glycoproteins appear dependent on N-glycosylation of Gn for correct folding, localization and transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197010     DOI: 10.1016/j.virol.2006.11.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.

Authors:  Marko Zivcec; Lisa I W Guerrero; César G Albariño; Éric Bergeron; Stuart T Nichol; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2017-08-24       Impact factor: 5.970

2.  Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein.

Authors:  Louis A Altamura; Andrea Bertolotti-Ciarlet; Jeffrey Teigler; Jason Paragas; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Mapping of the interaction domains of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Jesica M Levingston Macleod; Hannah Marmor; Adolfo García-Sastre; Natalia Frias-Staheli
Journal:  J Gen Virol       Date:  2014-11-11       Impact factor: 3.891

Review 4.  Immunobiology of Crimean-Congo hemorrhagic fever.

Authors:  Sergio E Rodriguez; David W Hawman; Teresa E Sorvillo; T Justin O'Neal; Brian H Bird; Luis L Rodriguez; Éric Bergeron; Stuart T Nichol; Joel M Montgomery; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2022-01-11       Impact factor: 10.103

5.  Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus.

Authors:  Helen Karlberg; Gunnel Lindegren; Ali Mirazimi
Journal:  Open Virol J       Date:  2010-04-22

6.  Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators.

Authors:  Olena Shtanko; Raisa A Nikitina; Cengiz Z Altuntas; Alexander A Chepurnov; Robert A Davey
Journal:  PLoS Pathog       Date:  2014-09-18       Impact factor: 6.823

7.  Crimean-Congo Hemorrhagic Fever Virus Gn Bioinformatic Analysis and Construction of a Recombinant Bacmid in Order to Express Gn by Baculovirus Expression System.

Authors:  Mehdi Rahpeyma; Fatemeh Fotouhi; Manouchehr Makvandi; Ata Ghadiri; Alireza Samarbaf-Zadeh
Journal:  Jundishapur J Microbiol       Date:  2015-11-21       Impact factor: 0.747

8.  The complete genome sequence of a Crimean-Congo hemorrhagic fever virus isolated from an endemic region in Kosovo.

Authors:  Darja Duh; Stuart T Nichol; Marina L Khristova; Ana Saksida; Iva Hafner-Bratkovic; Miroslav Petrovec; Iusuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Virol J       Date:  2008-01-15       Impact factor: 4.099

9.  A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.

Authors:  Karen R Buttigieg; Stuart D Dowall; Stephen Findlay-Wilson; Aleksandra Miloszewska; Emma Rayner; Roger Hewson; Miles W Carroll
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 10.  Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Marko Zivcec; Florine E M Scholte; Christina F Spiropoulou; Jessica R Spengler; Éric Bergeron
Journal:  Viruses       Date:  2016-04-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.